文献速递消化内镜消化道肿瘤与早癌

水下内镜黏膜切除术与传统内镜黏膜切除术治疗大型无蒂结直肠病变的多中心随机对照试验

Underwater versus conventional EMR of large nonpedunculated colorectal lesions: a multicenter randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2022-12-23

该多中心随机对照试验在西班牙11家医院纳入298例患者(311处病变),比较水下内镜黏膜切除术(UEMR)与传统内镜黏膜切除术(CEMR)治疗大型无蒂结直肠病变(LNPCL)的疗效与安全性。总体复发率无差异(9.5% vs 11.7%),但20-30mm病变UEMR复发率更低(3.4% vs 13.1%)。UEMR更快更易操作,安全性相当。

要点

  • 总体复发率UEMR 9.5% vs CEMR 11.7%,绝对风险差-2.2%(95%CI -9.4至4.9)
  • 20-30mm病变复发率UEMR 3.4% vs CEMR 13.1%,绝对风险差-9.7%(95%CI -19.4至0)
  • UEMR整体更快更易操作,两种技术安全性相当

核心结论

  • UEMR是治疗LNPCL的有效替代方案,对于20-30mm病变因整块切除率和R0切除率更高可考虑作为首选治疗。

研究设计与样本

  • 多中心随机对照临床试验,2018年2月至2020年2月在西班牙11家医院开展,共298例患者(311处病变)随机分入UEMR组(n=149)和CEMR组(n=162)。

主要发现

  • 总体复发率UEMR组9.5% vs CEMR组11.7%,绝对风险差-2.2%(95%CI -9.4至4.9),无差异。
  • 20-30mm病变复发率UEMR组3.4% vs CEMR组13.1%,绝对风险差-9.7%(95%CI -19.4至0)。
  • R0切除率呈现相同趋势,仅在20-30mm病变中UEMR显著优于CEMR。
  • UEMR整体比CEMR更快更易操作,两种技术安全性相当。

临床怎么用

  • UEMR可作为LNPCL的有效替代治疗方案,对于20-30mm病变因整块切除率和R0切除率更高可考虑作为首选治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Underwater EMR (UEMR) is an alternative procedure to conventional EMR (CEMR) to treat large, nonpedunculated colorectal lesions (LNPCLs). In this multicenter, randomized controlled clinical trial, we aimed to compare the efficacy and safety of UEMR versus CEMR on LNPCLs. METHODS: We conducted a multicenter, randomized controlled clinical trial from February 2018 to February 2020 in 11 hospitals in Spain. A total of 298 patients (311 lesions) were randomized to the UEMR (n = 149) and CEMR (n = 162) groups. The main outcome was the lesion recurrence rate in at least 1 follow-up colonoscopy. Secondary outcomes included technical aspects, en bloc resection rate, R0 resection rates, and adverse events, among others. RESULTS: There were no differences in the overall recurrence rate (9.5% UEMR vs 11.7% CEMR; absolute risk difference, -2.2%; 95% CI, -9.4 to 4.9). However, considering polyp sizes between 20 and 30 mm, the recurrence rate was lower for UEMR (3.4% UEMR vs 13.1% CEMR; absolute risk difference, -9.7%; 95% CI, -19.4 to 0). The R0 resection showed the same tendency, with significant differences favoring UEMR only for polyps between 20 and 30 mm. Overall, UEMR was faster and easier to perform than CEMR. Importantly, the techniques were equally safe. CONCLUSIONS: UEMR is a valid alternative to CEMR for treating LNPCLs and could be considered the first option of treatment for lesions between 20 and 30 mm due to its higher en bloc and R0 resection rates. (Clinical trial registration number: NCT03567746.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Rodríguez Sánchez J, Alvarez-Gonzalez MA, Pellisé M, et al. Underwater versus conventional EMR of large nonpedunculated colorectal lesions: a multicenter randomized controlled trial. Gastrointest Endosc. 2022. PMID: 36572129. doi:10.1016/j.gie.2022.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。